By continuing to use the site you agree to our Privacy & Cookies policy

NICE positive about lung cancer drug

Draft guidance has recommended afatinib (Giotrif) as a treatment for locally advanced, or metastatic, non-small-cell lung cancer.

Get unlimited access

As a subscriber you will benefit from:

  • Full online and mobile access to news and opinion stories
  • Customised email alerts straight to your inbox (over 30 alerts available)
  • 4,500 practice articles in our archive 
  • Over £500 worth of CPD learning units 
or

newsletterpromo